Intravenous Platelet Blockade with Cangrelor during PCI

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11120%2F09%3A00001908" target="_blank" >RIV/00216208:11120/09:00001908 - isvavai.cz</a>

Alternative codes found

RIV/00843989:_____/09:00103116

Result on the web

—

DOI - Digital Object Identifier

—

Result language

angličtina

Original language name

Intravenous Platelet Blockade with Cangrelor during PCI

Original language description

Intravenous cangrelor, a rapid-acting, reversible adenosine diphosphate (ADP) receptor antagonist, might reduce ischemic events during percutaneous coronary intervention (PCI). The use of periprocedural cangrelor during PCI was not superior to placebo inreducing the primary end point. The prespecified secondary end points of stent thrombosis and death were lower in the cangrelor group, with no significant increase in the rate of transfusion. Further study of intravenous ADP blockade with cangrelor maybe warranted. (ClinicalTrials.gov number, NCT00385138.)

Czech name

—

Czech description

—

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

FA - Cardiovascular diseases including cardio-surgery

OECD FORD branch

—

Project

—

Continuities

S - Specificky vyzkum na vysokych skolach

Publication year

2009

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

New England Journal of Medicine

ISSN

0028-4793

e-ISSN

—

Volume of the periodical

361

Issue of the periodical within the volume

24

Country of publishing house

US - UNITED STATES

Number of pages

12

Pages from-to

—

UT code for WoS article

000272547600007

EID of the result in the Scopus database

—